These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 18684735)

  • 61. Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection.
    Arce JC; Andersen AN; Fernández-Sánchez M; Visnova H; Bosch E; García-Velasco JA; Barri P; de Sutter P; Klein BM; Fauser BC
    Fertil Steril; 2014 Dec; 102(6):1633-40.e5. PubMed ID: 25256937
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone.
    Kolibianakis EM; Papanikolaou EG; Tournaye H; Camus M; Van Steirteghem AC; Devroey P
    Fertil Steril; 2007 Nov; 88(5):1382-8. PubMed ID: 17445806
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Corifollitropin alfa compared to daily FSH in controlled ovarian stimulation for oocyte donors].
    Benchabane M; Santulli P; Maignien C; Bourdon M; De Ziegler D; Chapron C; Gayet V
    Gynecol Obstet Fertil Senol; 2017 Feb; 45(2):83-88. PubMed ID: 28368800
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization].
    Chen SL; Sun L; Kong LH; Li L; Li J; Zhu L; Gao TM; Xing FQ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):526-9. PubMed ID: 17983490
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation.
    Filicori M; Cognigni GE; Gamberini E; Parmegiani L; Troilo E; Roset B
    Fertil Steril; 2005 Aug; 84(2):394-401. PubMed ID: 16084880
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial.
    Baker VL; Fujimoto VY; Kettel LM; Adamson GD; Hoehler F; Jones CE; Soules MR
    Fertil Steril; 2009 Apr; 91(4):1005-11. PubMed ID: 18367182
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer: a randomized double-blind clinical trial (NCT00461916).
    Safdarian L; Mohammadi FS; Alleyassin A; Aghahosseini M; Meysamie A; Rahimi E
    Hum Reprod; 2007 Sep; 22(9):2449-54. PubMed ID: 17635844
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A pilot study comparing corifollitropin alfa associated with hp-HMG versus high dose rFSH antagonist protocols for ovarian stimulation in poor responders.
    Mendret-Pellerin S; Leperlier F; Reignier A; Lefebvre T; Barrière P; Fréour T
    Hum Fertil (Camb); 2020 Jun; 23(2):93-100. PubMed ID: 30129813
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF.
    Verberg MF; Eijkemans MJ; Macklon NS; Heijnen EM; Fauser BC; Broekmans FJ
    Hum Reprod; 2007 Jul; 22(7):1919-24. PubMed ID: 17485438
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of patient characteristics on the pharmacokinetics of corifollitropin alfa during controlled ovarian stimulation.
    Zandvliet AS; Prohn M; de Greef R; van Aarle F; McCrary Sisk C; Stegmann BJ
    Br J Clin Pharmacol; 2016 Jul; 82(1):74-82. PubMed ID: 26991902
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Corifollitropin alfa: a new option to treat female infertility.
    de Lartigue J
    Drugs Today (Barc); 2011 Aug; 47(8):583-90. PubMed ID: 21850281
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Establishing the follitropin delta dose that provides a comparable ovarian response to 150 IU/day follitropin alfa.
    Arce JC; Larsson P; García-Velasco JA
    Reprod Biomed Online; 2020 Oct; 41(4):616-622. PubMed ID: 32819842
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Corifollitropin alfa in women stimulated for the first time in in vitro fertilization programme].
    Vraná-Mardešićová N; Vobořil J; Melicharová L; Jelínková L; Vilímová Š; Mardešić T
    Ceska Gynekol; 2017; 82(5):362-365. PubMed ID: 29020783
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis.
    Verberg MF; Eijkemans MJ; Macklon NS; Heijnen EM; Baart EB; Hohmann FP; Fauser BC; Broekmans FJ
    Hum Reprod Update; 2009; 15(1):5-12. PubMed ID: 19091754
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Corifollitropin alfa for ovarian stimulation in in vitro fertilization: a systematic review and meta-analysis of randomized controlled trials.
    Cozzolino M; Vitagliano A; Cecchino GN; Ambrosini G; Garcia-Velasco JA
    Fertil Steril; 2019 Apr; 111(4):722-733. PubMed ID: 30929731
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of results obtained with corifollitropin alfa after poor ovarian response in previous cycle using recombinant follicular stimulating hormone in the long-term protocol.
    Salgueiro LL; Rolim JR; Moura BR; Machado SP; Haddad C
    JBRA Assist Reprod; 2016 Aug; 20(3):123-6. PubMed ID: 27584604
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial.
    Andersen AN; Devroey P; Arce JC
    Hum Reprod; 2006 Dec; 21(12):3217-27. PubMed ID: 16873892
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility.
    Balen AH; Mulders AG; Fauser BC; Schoot BC; Renier MA; Devroey P; Struijs MJ; Mannaerts BM
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6297-304. PubMed ID: 15579793
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients.
    Smitz J; Andersen AN; Devroey P; Arce JC;
    Hum Reprod; 2007 Mar; 22(3):676-87. PubMed ID: 17110397
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Corifollitropin alfa vs recombinant FSH for controlled ovarian stimulation in women aged 35-42 years with a body weight ≥50 kg: a randomized controlled trial.
    Vuong NL; Pham DT; Phung HT; Giang HN; Huynh GB; Nguyen TTL; Ho MT
    Hum Reprod Open; 2017; 2017(3):hox023. PubMed ID: 30895237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.